Since the discovery of the antineoplastic agent cisplatin (c-DDP) by Rosenberg et al., 1) the drug has been in wide-spread use to date. However, because of its toxic side-effects, particularly renal damage, the search for safer platinum complexes and administration methods is still continuing. Several platinum and palladium containing compounds have subsequently been synthesized and tested. [2] [3] [4] One of these, carboplatin, was approved for treatment of ovarian cancer. 5) This has no kidney toxicity, there is less nausea, neurotoxicity, ototoxicity than cisplatin and the drug could be given without hydration treatment. 6) Recent work on the reaction mode of carboplatin focused on the intraction with DNA building blocks. 7) It was concluded that the reaction with carboplatin proceeds via a direct substitution mechanism, since the reaction with chloride was too slow to account for an aqua or chloro complex as the reactive species. [7] [8] [9] [10] [11] Tobe and Kokhar 12) reported that change in the amine ligands have primary effect on antitumor properties of platinum(II)/palladium(II) [Pt(II)/Pd(II)] complexes. Recent kinetic work by van Eldik and his co-workers. 13) on [Pd(bpy)(cbdca)] [where bpy is 2,2Ј-bipyridine and cbdca is anion of 1,1-cyclobutanedicarboxylic acid] indicates that a decrease in reactivity was induced by increasing the steric hindrance on the amine ligands, and attributed to the axial sites becoming blocked for the incoming ligands. On substitution the two monodentate amine groups of carboplatin with bpy, the resulting complexes have a UV-absorption band in a region where DNA does not show absorption. 14) This enable us to carry out DNA-binding studies using A.M.Q. King method. 15) Thus, in this paper we report the synthesis, characterization DNA-binding and cytotoxic studies of bpy Pt(II) and Pd(II) complexes containing cbdca which are analogous to carboplatin.
Experimental
Commercially pure chemicals: K 2 PtCl 4 , PdCl 2 , bpy, cbdca, highly polymerized calf thymus DNA sodium salt and Tris-HCl buffer were perchased from Aldrich U.S.A. and used as such. Solvents used were of laboratory reagent grade and they were purified before use by the standard methods. 16) Electronic absorption spectra of the titled metal complexes were measured on a Shimadzu UV-265 recording spectrophotometer. Infrared spectra of the metals complexes were recorded on a Nicolet 5-DXB FT-IR spectrophotometer in the range of 4000-400 cm Ϫ1 in KBr pellets. Conductivity measurements were carried out on a Systronics conductivity bridge, model 305, with a cell (cell constant 0.59) using conductivity water as a solvent. Micro chemical analysis of carbon, hydrogen and nitrogen for the complexes were carried out on an elemental analysis of CHNO-Rapid Herause.
1 H-NMR spectra were recorded on a Brucker DRX-500 Avance spectrometer at 500 MHz in D 2 O using sodium 3-trimethylpropionate as internal reference. Fluorescence measurements were carried out on a SPEX-Fluorolog spectrofluorimeter equipped with 1681, 0.22 m double spectrometer and DMIB spectroscopy laboratory coordination using a 1 cm 2 spectrofluorimeter quartz cuvette.
Synthesis of Pd(II) and Pt(II) Compounds [Pt(bpy)Cl 2 ] and [Pd(bpy)Cl 2 ] were prepared by the procedures followed for making analogous bpy complexes. 17) [Pt(bpy)(cbdca)]: [Pt(bpy)Cl 2 ] (420 mg, 1 mmol) was suspended in 100 ml double distilled water and 19.7 ml of 0.10 M AgNO 3 (1.97 mmol) solution was added to it with constant stirring. This mixture was heated at 60°C with stirring under dark for 6 h at 55°C and then 16 h at room temparature (28°C). The AgCl precipitate was removed by centrifugation. The clear solution was filtered through Whatman 42 filter paper and mixed with cbdca (144 mg, 1 mmol) and sodium bicarbonate (168 mg, 2 mmol). The reaction mixture was again stirred for 12 h at 50°C and then filtered in hot. The clear solution was concentrated on water bath at 45°C to 5 ml. The yellow precipitate were filtered, washed with small amount of chilled double distilled water and finally recrystallized from double distilled water and dried in vacuum desiccator over anhydrous calcium chloride. Cytotoxic Studies The procedure followed was similar to that reported earlier 18) except that 2ϫ10 6 P 388 lymphocytic leukemia cells per ml were used in place of 1ϫ10 6 P 388 cells per ml in Tris-HCl buffer solution. Binding Studies The difference UV absorption and fluorecence methods were used to determine the binding of metal complexes to DNA as described earlier 18, 19) except that the metal complexes-DNA systems were incubated at 37°C for 10 h before spectral measurements. 
20)
Spectral Studies The selective infrared spectral data of the Pt(II) and Pd(II) complexes in the range 4000 to 400 cm Ϫ1 are discussed. The infrared spectra of cbdca in KBr pellets showed a strong band at 1700 cm Ϫ1 which is assigned to the COOH stretching band of this ligand. 21) In the Pt(II) and Pd(II) complexes the COO stretching band is observed at 1655 and 1642 cm Ϫ1 , respectively. This suggest that the carboxyl groups of the above dicarboxylic acid is coordinated as bidentate through two oxygen atoms 22) as shown in Fig. 1 . The electronic absorption maxima of the Pt(II) and Pd(II) complexes in distilled water with their extinction coefficients are given in the experimental section. The band at 318 nm for Pt(II) and at 309 nm for Pd(II) complexes is tentatively assigned to charge-transfer transition from platinum or palladium d-orbital to p* orbital of a-diimine. Other bands are assigned to first, second, and higher internal transitions of adiimine. 23) In the 1 H-NMR spectrum of cbdca (pH*ϭ7.00), 2ϩ have been compared. The 1 H resonances of the bpy ligand in these two complexes, appear at d 8.30 and 7.72 respectively. These small shift differences of bpy ligand, can be due to replacement of dicarboxylate by water which are both oxygen donor ligands.
The above NMR data are in good agreement with the results already obtained by van Eldik and his co-workers. Cytotoxic Studies The a-diimine Pd(II) and Pt(II) complexes with cbdca ligand were screened for their cytotoxicity against P 388 lymphocytic leukemia cells. 24) The ID 50 values of the Pt(II) and Pd(II) complexes found to be 5 and 6 mmol/l, respectively. These values are much lower than cisplatin. 25) These growth inhibition studies suggest that the target of these complexes is DNA of the cancer cells. Therefore, the interaction of these complexes with highly polymerized calf thymus DNA have been carried out as given below.
Binding Studies The interaction of [Pt(bpy)(cbdca)] and [Pd(bpy)(cbdca)] in 10 mM Tris-HCl buffer of pH 7.4 in the presence of 0.01 M sodium chloride with calf thymus DNA was studied using difference absorption spectroscopy. 19) The hypochromic effect observed in the absorption spectra of [Pt(bpy)(cbdca)] and [Pd(bpy)(cbdca)] in presence of increasing concentrations of DNA is shown in Figs. 2a and b , respectively. Two isosbestic points are obtained at 323 and 310 nm for platinum complex (see Fig. 2a ) and 318 and 300 nm for palladium complex (see Fig. 2b ). This indicates that there is an equilibrium between bound and free forms of the metal complexes with DNA. The change in absorbance was measured at 319 nm for [Pt(bpy)(cbdca)]-DNA system and at 314 nm for [Pd(bpy)(cbdca)]-DNA system. The binding isotherms were constructed from these data using the Scatchard equation.
26) The Scatchard plot obtained on titration of DNA (24 mM The fluorescence of ethidium bromide (EtBr) is greatly enhanced upon interaction of EtBr to DNA. 29, 30) The influence of binding of some a-diimine Pt(II) and Pd(II) complexes of cbdca on the fluorescence intensity of EtBr-DNA complex has been studied. The number of EtBr molecules intercalated to DNA in the presence of [Pt(bpy)(cbdca)] and [Pd(bpy)-(cbdca)] were calculated using Scatchard analysis. 26) In these experiments the wavelength of excitation was set at 546 nm and the wavelength of emission at 605 nm. 31) in which the slope that is K (association constant) remain constant while the intercept on the absissa that is n (the number of binding sites per nucleotide) decrease with increasing concentrations of metal complex. This suggests that the [Pt(bpy)(cbdca)] binds to DNA via nonintercalating mode. The values of K and n are listed in Table 1 . Similar Scatchard plots have been observed for [Pd(bpy)(cbdca)]. 27) Other studies have also been carried out to determine the mode of the above interaction as followd. 27) Each of the above metal complexes (48 mM) was incubated with calf thymus DNA (120 mM) for 10 h at 37°C in Tris-HCl buffer pH 7.4. Each DNA-metal complex was passed through a Sephadex G.25 column equilibrated with same buffer. The elution of the column fraction of 2.5 ml was monitored at 319 and 259 nm for DNA-Pt(II) complex systems and 314 and 259 nm for DNA-Pd(II) complex systems. These results are given in Figs. 5a and b, respectively. These plots show that the peak obtained for the two wavelengths were not clearly resolved. This indicates that the DNA is not separated from the metal complexes and their binding to DNA is covalent and irreversible. The irreversible binding of metal complex to DNA is strictly true for kinetically inert Pt(II)-DNA complex and there is expected partial reversibility for kinetic labile Pd(II)-DNA complex as observed above. The precipitation of DNA from DNA-metal complex with absolute alcohol was also attempted. The presence of DNA-metal complex in the precipitate suggests the coordinate covalent bond which is responsible for stabilizing the above DNA-metal complexes.
Studies with heat denatured DNA show virtually no reversal in the binding of metal complex to DNA as compared to the native DNA. This suggests that the metal complex is strongly binding to denatured single stranded DNA.
Conclusions
Two water soluble complexes of formula [M(bpy)(cbdca)] which are analogous to carboplatin have been prepared by interacting appropriate a-diiminePt(II) and Pd(II) compounds with cbdca sodium salt. These complexes have been found to be better cytotoxic agents than cisplatin against P 388 lymphocytic leukemia cells. [M(bpy)(cbdca)] complexes bind to calf thymus DNA through coordinate covalent bond as suggested earlier for the binding of cisplatin to DNA.
